Gabapentin for the Treatment of Vulvodynia: A Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate whether extended-release gabapentin is more effective than placebo among women with vulvodynia. METHODS: In a multicenter double-blind, placebo-controlled randomized crossover trial, gabapentin (1,200–3,000 mg/d) was compared with a placebo. The primary outcome was mean pain intensity (0, no pain at all to 10, worst pain ever) on the tampon test (a standardized tampon insertion and removal test used as a surrogate marker for dyspareunia) during the last 7 days of the maintenance phase. Secondary outcomes included sexual intercourse pain and daily pain. A sample size of 53 provided 90% power to detect a 1-point reduction on the tampon test (.05 level, two-sided) between the two treatment phases. RESULTS: From August 2012 to January 2016, 230 women were screened at three academic institutions and 89 (mean age 37 years; 65% black) were randomized: 45 to gabapentin first and then placebo and 44 to placebo first and then gabapentin. Tampon test pain with gabapentin was not different compared with the placebo (adjusted mean 4.0, 95% CI 3.0–4.9 vs 4.3, 95% CI 3.4–5.2, difference −0.3, 95% CI −0.7 to 0.0; P=.07). Gabapentin also did not improve pain over placebo for sexual intercourse pain (adjusted mean 3.9, 95% CI 2.4–5.3 vs 4.0, 95% CI 2.5–5.4, difference −0.1, 95% CI −0.9 to 0.6; P=.76) and daily pain (adjusted mean 2.7, 95% CI 1.8–3.6 vs 2.9, 95% CI 2.0–3.8, difference −0.2, 95% CI −0.5 to −0.2; P=.36). Subset analyses found that longer pain duration and oral contraceptive nonuse were associated with minimal improvement in tampon test pain with gabapentin. CONCLUSION: In this cohort, extended-release gabapentin, as compared with a placebo, did not reduce tampon test pain. These data do not support the recommendation of gabapentin alone as treatment for vulvodynia. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT01301001.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471
Understanding the Hawthorne effect
Sedgwick, P., & Greenwood, N. (2015) · BMJ · doi:10.1136/bmj.h4672 · Cited by 824
Prevalence and demographic characteristics of vulvodynia in a population-based sample
Reed, B. D., Harlow, S. D., Sen, A., Legocki, L. J., Edwards, R. M., Arato, N., & Haefner, H. K. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.08.012 · Cited by 317
Bornstein, J., Goldstein, A. T., Stockdale, C. K., Bergeron, S., Pukall, C., Zolnoun, D., & Coady, D. (2016) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001359 · Cited by 261
Interpreting Incomplete Data in Studies of Diet and Weight Loss
Ware, J. H. (2003) · New England Journal of Medicine · doi:10.1056/nejme030054 · Cited by 205
Vulvodynia - an evidence-based literature review and proposed treatment algorithm
De Andres, J., Sanchis‐Lopez, N., Asensio‐Samper, J. M., Fabregat‐Cid, G., Villanueva‐Perez, V. L., Monsalve Dolz, V., & Minguez, A. (2016) · Pain Practice · doi:10.1111/papr.12274 · Cited by 127
Vulvodynia Incidence and Remission Rates Among Adult Women: A 2-Year Follow-up Study
Reed, B. D., Haefner, H. K., Sen, A., & Gorenflo, D. W. (2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318180965b · Cited by 85
Foster, D. C., Beth Kotok, M., Huang, L.-S., Watts, A., Oakes, D., Howard, F. M., Stodgell, C. J., & Dworkin, R. H. (2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31819bda7c · Cited by 83
Self-citation
Cited by
Chronic Pelvic Pain in Women: A Review
Lamvu, G., Carrillo, J., Ouyang, C., & Rapkin, A. (2021) · JAMA · doi:10.1001/jama.2021.2631 · Cited by 388
Bergeron, S., Reed, B. D., Wesselmann, U., & Bohm-Starke, N. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0164-2 · Cited by 158
Brotto, L. A., Bergeron, S., Zdaniuk, B., Driscoll, M., Grabovac, A., Sadownik, L. A., Smith, K. B., & Basson, R. (2019) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2019.04.002 · Cited by 87
Treatment of vulvodynia: pharmacological and non-pharmacological approaches
Rosen, N. O., Dawson, S. J., Brooks, M., & Kellogg-Spadt, S. (2019) · Drugs · doi:10.1007/s40265-019-01085-1 · Cited by 83
Treatment of provoked vulvodynia: a systematic review
Bohm-Starke, N., Ramsay, K. W., Lytsy, P., Nordgren, B., Sjöberg, I., Moberg, K., & Flink, I. (2022) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2022.02.008 · Cited by 51
Metadata
- Authors
- Brown, C. S., Bachmann, G. A., Wan, J., Foster, D. C., & for the Gabapentin (GABA) Study Group
- Venue
- Obstetrics & Gynecology
- Published
- 2018-06
- Volume
- 131
- Issue
- 6
- Pages
- 1000-1007
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2800491868
- Cited by
- 58
- References
- 8
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gabapentin for the Treatment of Vulvodynia: A Randomized Controlled Trial. https://app.cochat.ai/papers/10.1097/aog.0000000000002617
- The paper
- Brown, C. S., Bachmann, G. A., Wan, J., Foster, D. C., & for the Gabapentin (GABA) Study Group. (2018). Gabapentin for the Treatment of Vulvodynia: A Randomized Controlled Trial. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000002617
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.